| David A. Ricks | Chair, President, and Chief Executive Officer | FY2025 | |
| Daniel M. Skovronsky, M.D., Ph.D. | Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Labs | FY2025 | |
| Anat Hakim | Executive Vice President, General Counsel and Secretary | FY2025 | |
| Lucas Montarce | Executive Vice President and Chief Financial Officer | FY2025 | |
| Jake Van Naarden | Executive Vice President and President, Lilly Oncology and Head of Corporate Business Development | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.